About this Journal Submit a Manuscript Table of Contents
Scientifica
Volume 2013 (2013), Article ID 965856, 7 pages
http://dx.doi.org/10.1155/2013/965856
Review Article

The Role of Sialic Acid-Binding Receptors (Siglecs) in the Immunomodulatory Effects of Trypanosoma cruzi Sialoglycoproteins on the Protective Immunity of the Host

Institute of Microbiology, Federal University of Rio de Janeiro, CCS, Sala D1-035, Avenida Carlos Chagas Filho 373, Cidade Universitária, Ilha do Fundão, 21.941-902 Rio de Janeiro, RJ, Brazil

Received 17 November 2013; Accepted 10 December 2013

Academic Editors: M. Salio, A. R. Satoskar, R. Teasdale, and A. G. Zapata

Copyright © 2013 Alexandre Morrot. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. L. Ribeiro, M. P. Nunes, M. M. Teixeira, and M. O. Rocha, “Diagnosis and management of Chagas disease and cardiomyopathy,” Nature Reviews Cardiology, vol. 9, pp. 576–589, 2012.
  2. M. A. Barry, J. E. Weatherhead, P. J. Hotez, and L. Woc-Colburn, “Childhood parasitic infections endemic to the United States,” Pediatric Clinics of North America, vol. 60, pp. 471–485, 2013.
  3. E. S. Garcia, F. A. Genta, P. de Azambuja, and G. A. Schaub, “Interactions between intestinal compounds of triatomines and Trypanosoma cruzi,” Trends in Parasitology, vol. 26, no. 10, pp. 499–505, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Ortega-Barria and M. E. Pereira, “Entry of Trypanosoma cruzi into eukaryotic cells,” Infectious Agents and Disease, vol. 1, no. 3, pp. 136–145, 1992. View at Scopus
  5. B. A. Burleigh and A. M. Woolsey, “Cell signalling and Trypanosoma cruzi invasion,” Cellular Microbiology, vol. 4, no. 11, pp. 701–711, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. W. de Souza, T. M. de Carvalho, and E. S. Barrias, “Review on Trypanosoma cruzi: host cell interaction,” International Journal of Cell Biology, vol. 2010, Article ID 295394, 18 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. C. Fernandes and N. W. Andrews, “Host cell invasion by Trypanosoma cruzi: a unique strategy that promotes persistence,” FEMS Microbiology Reviews, vol. 36, no. 3, pp. 734–747, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Nagajyothi, F. S. Machado, B. A. Burleigh et al., “Mechanisms of Trypanosoma cruzi persistence in Chagas disease,” Cellular Microbiology, vol. 14, no. 5, pp. 634–643, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Y. Maeda, C. Cortez, and N. Yoshida, “Cell signaling during Trypanosoma cruzi invasion,” Frontiers in Immunology, vol. 3, article 361, 2012.
  10. H. B. Tanowitz, J. P. Gumprecht, D. Spurr et al., “Cytokine gene expression of endothelial cells infected with Trypanosoma cruzi,” Journal of Infectious Diseases, vol. 166, no. 3, pp. 598–603, 1992. View at Scopus
  11. H. Huang, T. M. Calderon, J. W. Berman et al., “Infection of endothelial cells with Trypanosoma cruzi activates NF-κB and induces vascular adhesion molecule expression,” Infection and Immunity, vol. 67, no. 10, pp. 5434–5440, 1999. View at Scopus
  12. B. Chandrasekar, P. C. Melby, D. A. Troyer, and G. L. Freeman, “Differential regulation of nitric oxide synthase isoforms in experimental acute Chagasic cardiomyopathy,” Clinical and Experimental Immunology, vol. 121, no. 1, pp. 112–119, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. M. M. Teixeira, R. T. Gazzinelli, and J. S. Silva, “Chemokines, inflammation and Trypanosoma cruzi infection,” Trends in Parasitology, vol. 18, no. 6, pp. 262–265, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Mukherjee, H. Huang, S. B. Petkova et al., “Trypanosoma cruizi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells,” Infection and Immunity, vol. 72, no. 9, pp. 5274–5282, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Prata, “Clinical and epidemiological aspects of Chagas disease,” The Lancet Infectious Diseases, vol. 1, no. 2, pp. 92–100, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Gironès, H. Cuervo, and M. Fresno, “Trypanosoma cruzi-induced molecular mimicry and Chagas' disease,” Current Topics in Microbiology and Immunology, vol. 296, pp. 89–123, 2005. View at Scopus
  17. F. R. Gutierrez, P. M. Guedes, R. T. Gazzinelli, and J. S. Silva, “The role of parasite persistence in pathogenesis of Chagas heart disease,” Parasite Immunology, vol. 31, no. 11, pp. 673–685, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Cunha-Neto, P. C. Teixeira, L. G. Nogueira, and J. Kalil, “Autoimmunity,” Advances in Parasitology, vol. 76, pp. 129–152, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. C. R. Marinho, M. R. D'Império Lima, M. G. Grisotto, and J. M. Alvarez, “Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease,” Infection and Immunity, vol. 67, no. 1, pp. 308–318, 1999. View at Scopus
  20. P. Minoprio, S. Itohara, C. Heusser, S. Tonegawa, and A. Coutinho, “Immunobiology of murine T. Cruzi infection: the predominance of parasite-nonspecific responses and the activation of TCRI T cells,” Immunological Reviews, no. 112, pp. 183–207, 1989. View at Scopus
  21. A. Ouaissi, A. C. da Silva, A. G. Guevara, M. Borges, and E. Guilvard, “Trypanosoma cruzi-induced host immune system dysfunction: a rationale for parasite immunosuppressive factor(s) encoding gene targeting,” Journal of Biomedicine and Biotechnology, vol. 1, no. 1, pp. 11–17, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. A. M. Acosta and C. A. Santos-Buch, “Autoimmune myocarditis induced by Trypanosoma cruzi,” Circulation, vol. 71, no. 6, pp. 1255–1261, 1985. View at Scopus
  23. F. Kierszenbaum, “Chagas' disease and the autoimmunity hypothesis,” Clinical Microbiology Reviews, vol. 12, no. 2, pp. 210–223, 1999. View at Scopus
  24. D. M. Engman and J. S. Leon, “Pathogenesis of Chagas heart disease: role of autoimmunity,” Acta Tropica, vol. 81, no. 2, pp. 123–132, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Klein, M. Hinterberger, G. Wirnsberger, and B. Kyewski, “Antigen presentation in the thymus for positive selection and central tolerance induction,” Nature Reviews Immunology, vol. 9, no. 12, pp. 833–844, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Basten and P. A. Silveira, “B-cell tolerance: mechanisms and implications,” Current Opinion in Immunology, vol. 22, no. 5, pp. 566–574, 2010.
  27. K. Pieper, B. Grimbacher, and H. Eibel, “B-cell biology and development,” Journal of Allergy and Clinical Immunology, vol. 131, no. 4, pp. 959–971, 2013.
  28. A. A. Freitas and B. Rocha, “Population biology of lymphocytes: the flight for survival,” Annual Review of Immunology, vol. 18, pp. 83–111, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. R. A. Willis, J. W. Kappler, and P. C. Marrack, “CD8 T cell competition for dendritic cells in vivo is an early event in activation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 32, pp. 12063–12068, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Montaudouin, M. Anson, Y. Hao et al., “Quorum sensing contributes to activated IgM-secreting B cell homeostasis,” Journal of Immunology, vol. 190, no. 1, pp. 106–114, 2013.
  31. F. Y. Liew, M. T. Scott, D. S. Liu, and S. L. Croft, “Suppressive substance produced by T cells from mice chronically infected with Trypanosoma cruzi. I. Preferential inhibition of the induction of delayed-type hypersensitivity,” Journal of Immunology, vol. 139, no. 7, pp. 2452–2457, 1987. View at Scopus
  32. F. Kierszenbaum, J. L. de Diego, M. Fresno, and M. B. Sztein, “Inhibitory effects of the Trypanosoma cruzi membrane glycoprotein AGC10 on the expression of IL-2 receptor chains and secretion of cytokines by subpopulations of activated human T lymphocytes,” European Journal of Immunology, vol. 29, pp. 1684–1691, 1999.
  33. F. Kierszenbaum, M. Fresno, and M. B. Sztein, “The Trypanosoma cruzi membrane glycoprotein AGC10 inhibits human lymphocyte activation by a mechanism preceding translation of both, interleukin-2 and its high-affinity receptor subunits,” Molecular and Biochemical Parasitology, vol. 125, no. 1-2, pp. 91–101, 2002. View at Scopus
  34. L. van Overtvelt, M. Andrieu, V. Verhasselt et al., “Trypanosoma cruzi down-regulates lipopolysaccharide-induced MHC class I on human dendritic cells and impairs antigen presentation to specific CD8+ T lymphocytes,” International Immunology, vol. 14, no. 10, pp. 1135–1144, 2002. View at Scopus
  35. S. Zambrano-Villa, D. Rosales-Borjas, J. C. Carrero, and L. Ortiz-Ortiz, “How protozoan parasites evade the immune response,” Trends in Parasitology, vol. 18, no. 6, pp. 272–278, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Alcaide and M. Fresno, “The Trypanosoma cruzi membrane mucin AgC10 inhibits T cell activation and IL-2 transcription through L-selectin,” International Immunology, vol. 16, no. 10, pp. 1365–1375, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. F. R. Gutierrez, P. M. Guedes, R. T. Gazzinelli, and J. S. Silva, “The role of parasite persistence in pathogenesis of Chagas heart disease,” Parasite Immunology, vol. 31, no. 11, pp. 673–685, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. A. M. Padilla, L. J. Simpson, and R. L. Tarleton, “Insufficient TLR activation contributes to the slow development of CD8+ T cell responses in Trypanosoma cruzi infection,” Journal of Immunology, vol. 183, no. 2, pp. 1245–1252, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. M. J. Pinazo, G. Espinosa, C. Cortes-Lletget et al., “Immunosuppression and Chagas disease: a management challenge,” PLOS Neglected Tropical Diseases, vol. 7, no. 1, Article ID e1965, 2013.
  40. A. Morrot, E. Terra-Granado, A. R. Pérez et al., “Chagasic thymic atrophy does not affect negative selection but results in the export of activated CD4+CD8+ T cells in severe forms of human disease,” PLoS Neglected Tropical Diseases, vol. 5, no. 8, Article ID e1268, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. V. Cotta-de-Almeida, Á. L. Bertho, D. M. S. Villa-Verde, and W. Savino, “Phenotypic and functional alterations of thymic nurse cells following acute Trypanosoma cruzi infection,” Clinical Immunology and Immunopathology, vol. 82, no. 2, pp. 125–132, 1997. View at Publisher · View at Google Scholar · View at Scopus
  42. V. Cotta-de-Almeida, A. Bonomo, D. A. Mendes-da-Cruz et al., “Trypanosoma cruzi infection modulates intrathymic contents of extracellular matrix ligands and receptors and alters thymocyte migration,” European Journal of Immunology, vol. 33, no. 9, pp. 2439–2448, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. W. Savino, D. A. Mendes-da-Cruz, S. Smaniotto, E. Silva-Monteiro, and D. M. Serra Villa-Verde, “Molecular mechanisms governing thymocyte migration: combined role of chemokines and extracellular matrix,” Journal of Leukocyte Biology, vol. 75, no. 6, pp. 951–961, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. D. A. Mendes-da-Cruz, J. S. Silva, V. Cotta-de-Almeida, and W. Savino, “Altered thymocyte migration during experimental acute Trypanosoma cruzi infection: combined role of fibronectin and the chemokines CXCL12 and CCL4,” European Journal of Immunology, vol. 36, no. 6, pp. 1486–1493, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. J. de Meis, A. Morrot, D. A. Farias-de-Oliveira, D. M. S. Villa-Verde, and W. Savino, “Differential regional immune response in Chagas disease,” PLoS Neglected Tropical Diseases, vol. 3, no. 7, article e417, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Hofmann, A. Oschowitzer, S. R. Kurzhals, C. C. Krüger, and H. Pircher, “Thymus-resident memory CD8+ T cells mediate local immunity,” European Journal of Immunology, vol. 43, no. 9, pp. 2295–2304, 2013.
  47. E. V. Acosta Rodriguez, E. I. Zuniga, C. L. Montes et al., “Trypanosoma cruzi infection beats the B-cell compartment favouring parasite establishment: can we strike first?” Scandinavian Journal of Immunology, vol. 66, no. 2-3, pp. 137–142, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. G. A. DosReis, “Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease,” Brazilian Journal of Medical and Biological Research, vol. 44, no. 2, pp. 84–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. M. E. Giorgi and R. M. de Lederkremer, “Trans-sialidase and mucins of Trypanosoma cruzi: an important interplay for the parasite,” Carbohydrate Research, vol. 346, no. 12, pp. 1389–1393, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. L. M. de Pablos and A. Osuna, “Multigene families in Trypanosoma cruzi and their role in infectivity,” Infection and Immunity, vol. 80, no. 7, pp. 2258–2264, 2012.
  51. G. A. DosReis, C. G. Freire-de-Lima, M. P. Nunes, and M. F. Lopes, “The importance of aberrant T-cell responses in Chagas disease,” Trends in Parasitology, vol. 21, no. 5, pp. 237–243, 2005.
  52. F. R. Gutierrez, P. M. Guedes, R. T. Gazzinelli, and J. S. Silva, “The role of parasite persistence in pathogenesis of Chagas heart disease,” Parasite Immunology, vol. 31, no. 11, pp. 673–685, 2009.
  53. F. Nagajyothi, F. S. Machado, B. A. Burleigh et al., “Mechanisms of Trypanosoma cruzi persistence in Chagas disease,” Cellular Microbiology, vol. 14, no. 5, pp. 634–643, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. I. A. Abrahamsohn and R. L. Coffman, “Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection,” Journal of Immunology, vol. 155, no. 8, pp. 3955–3963, 1995. View at Scopus
  55. G. A. Martins, M. A. G. Cardoso, J. C. S. Aliberti, and J. S. Silva, “Nitric oxide-induced apoptotic cell death in the acute phase of Trypanosoma cruzi infection in mice,” Immunology Letters, vol. 63, no. 2, pp. 113–120, 1998. View at Publisher · View at Google Scholar · View at Scopus
  56. M. P. Nunes, R. M. Andrade, M. F. Lopes, and G. A. DosReis, “Activation-induced T cell death exacerbates Trypanosoma cruzi replication in macrophages cocultured with CD4+ T lymphocytes from infected hosts,” Journal of Immunology, vol. 160, no. 3, pp. 1313–1319, 1998. View at Scopus
  57. S. Schenkman, M. S. Jiang, G. W. Hart, and V. Nussenzweig, “A novel cell surface trans-sialidase of Trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells,” Cell, vol. 65, no. 7, pp. 1117–1125, 1991. View at Scopus
  58. S. Schenkman, D. Eichinger, M. E. A. Pereira, and V. Nussenzweig, “Structural and functional properties of Trypanosoma trans-sialidase,” Annual Review of Microbiology, vol. 48, pp. 499–523, 1994. View at Scopus
  59. J. O. Previato, C. Jones, M. T. Xavier et al., “Structural characterization of the major glycosylphosphatidylinositol membrane-anchored glycoprotein from epimastigote forms of Trypanosoma cruzi Y-strain,” Journal of Biological Chemistry, vol. 270, no. 13, pp. 7241–7250, 1995. View at Publisher · View at Google Scholar · View at Scopus
  60. M. E. Giorgi and R. M. de Lederkremer, “Trans-sialidase and mucins of Trypanosoma cruzi: an important interplay for the parasite,” Carbohydrate Research, vol. 346, no. 12, pp. 1389–1393, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. J. M. di Noia, D. O. Sanchez, and A. C. C. Frasch, “The protozoan Trypanosoma cruzi has a family of genes resembling the mucin genes of mammalian cells,” Journal of Biological Chemistry, vol. 270, no. 41, pp. 24146–24149, 1995. View at Publisher · View at Google Scholar · View at Scopus
  62. C. A. Buscaglia, V. A. Campo, A. C. C. Frasch, and J. M. di Noia, “Trypanosoma cruzi surface mucins: host-dependent coat diversity,” Nature Reviews Microbiology, vol. 4, no. 3, pp. 229–236, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. L. Mendonça-Previato, L. Penha, T. C. Garcez, C. Jones, and J. O. Previato, “Addition of α-O-GlcNAc to threonine residues define the post-translational modification of mucin-like molecules in Trypanosoma cruzi,” Glycoconjugate Journal, vol. 30, no. 7, pp. 659–666, 2013.
  64. K. Joiner, A. Sher, T. Gaither, and C. Hammer, “Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 17, pp. 6593–6597, 1986. View at Scopus
  65. R. T. Gazzinelli, M. E. S. Pereira, A. Romanha, G. Gazzinelli, and Z. Brener, “Direct lysis of Trypanosoma cruzi: a novel effector mechanism of protection mediated by human anti-gal antibodies,” Parasite Immunology, vol. 13, no. 4, pp. 345–356, 1991. View at Scopus
  66. T. L. Kipnis, J. R. David, and C. A. Alper, “Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophages,” Proceedings of the National Academy of Sciences of the United States of America, vol. 78, no. 1, pp. 602–605, 1981. View at Scopus
  67. V. L. Pereira-Chioccola, A. Acosta-Serrano, I. C. de Almeida et al., “Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-α-galactosyl antibodies,” Journal of Cell Science, vol. 113, no. 7, pp. 1299–1307, 2000. View at Scopus
  68. H. Erdmann, C. Steeg, F. Koch-Nolte, B. Fleischer, and T. Jacobs, “Sialylated ligands on pathogenic Trypanosoma cruzi interact with Siglec-E (sialic acid-binding Ig-like lectin-E),” Cellular Microbiology, vol. 11, no. 11, pp. 1600–1611, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. M. P. Nunes, B. Fortes, J. L. Silva-Filho et al., “Inhibitory effects of Trypanosoma cruzi sialoglycoproteins on CD4+ T Cells are associated with increased susceptibility to infection,” PLoS ONE, vol. 8, no. 10, Article ID e77568, 2013.
  70. S. Pillai, I. A. Netravali, A. Cariappa, and H. Mattoo, “Siglecs and immune regulation,” Annual Review of Immunology, vol. 30, pp. 357–392, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. D. A. Bermejo, S. W. Jackson, M. Gorosito-Serran et al., “Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cells,” Nature Immunology, vol. 14, pp. 514–522, 2013.
  72. H. Erdmann, C. Steeg, F. Koch-Nolte, B. Fleischer, and T. Jacobs, “Sialylated ligands on pathogenic Trypanosoma cruzi interact with Siglec-E (sialic acid-binding Ig-like lectin-E),” Cellular Microbiology, vol. 11, no. 11, pp. 1600–1611, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. T. Jacobs, H. Erdmann, and B. Fleischer, “Molecular interaction of Siglecs (sialic acid-binding Ig-like lectins) with sialylated ligands on Trypanosoma cruzi,” European Journal of Cell Biology, vol. 89, no. 1, pp. 113–116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. P. R. Crocker, J. C. Paulson, and A. Varki, “Siglecs and their roles in the immune system,” Nature Reviews Immunology, vol. 7, no. 4, pp. 255–266, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. Z. Yu, M. Maoui, L. Wu, D. Banville, and S. Shen, “mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2,” Biochemical Journal, vol. 353, no. 3, pp. 483–492, 2001. View at Publisher · View at Google Scholar · View at Scopus
  76. J. Q. Zhang, B. Biedermann, L. Nitschke, and P. R. Crocker, “The murine inhibitory receptor mSiglec-E is expressed broadly on cells of the innate immune system whereas mSiglec-F is restricted to eosinophils,” European Journal of Immunology, vol. 34, no. 4, pp. 1175–1184, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. T. L. Tinder, D. B. Subramani, G. D. Basu et al., “MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma,” Journal of Immunology, vol. 181, no. 5, pp. 3116–3125, 2008. View at Scopus
  78. P. Allavena, M. Chieppa, G. Bianchi et al., “Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages,” Clinical and Developmental Immunology, vol. 2010, Article ID 547179, 10 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Ohta, A. Ishida, M. Toda et al., “Immunomodulation of monocyte-derived dendritic cells through ligation of tumor-produced mucins to Siglec-9,” Biochemical and Biophysical Research Communications, vol. 402, no. 4, pp. 663–669, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. T. Freire, R. Lo-Man, S. Bay, and C. Leclerc, “Tn glycosylation of the MUC6 protein modulates its immunogenicity and promotes the induction of Th17-biased T cell responses,” Journal of Biological Chemistry, vol. 286, no. 10, pp. 7797–7811, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. A. Anandkumar and H. Devaraj, “Tumor Immunomodulation: mucins in resistance to initiation and maturation of immune response against tumors,” Scandinavian Journal of Immunology, vol. 78, no. 1, pp. 1–7, 2013.
  82. C. Charvet, A. J. Canonigo, S. Bécart et al., “Vav1 promotes T cell cycle progression by linking TCR/CD28 costimulation to FOXO1 and p27kip1 expression,” Journal of Immunology, vol. 177, pp. 5024–5031, 2006.
  83. A. Jatzek, M. M. Tejera, A. Singh, J. A. Sullivan, E. H. Plisch, and M. Suresh, “p27(Kip1) negatively regulates the magnitude and persistence of CD4 T cell memory,” Journal of Immunology, vol. 189, pp. 5119–5128, 2012.
  84. C. M. Sawai, J. Freund, P. Oh et al., “Therapeutic targeting of the cyclin D3:CDK4/6 complex in T cell leukemia,” Cancer Cell, vol. 22, pp. 452–465, 2012.
  85. A. Deshpande, P. Sicinski, and P. W. Hinds, “Cyclins and cdks in development and cancer: a perspective,” Oncogene, vol. 24, no. 17, pp. 2909–2915, 2005. View at Publisher · View at Google Scholar · View at Scopus
  86. W. Wu, D. C. Munday, G. Howell, G. Platt, J. N. Barr, and J. A. Hiscox, “Characterization of the interaction between human respiratory syncytial virus and the cell cycle in continuous cell culture and primary human airway epithelial cells,” Journal of Virology, vol. 85, no. 19, pp. 10300–10309, 2011. View at Publisher · View at Google Scholar · View at Scopus